Home > News > BioTrove, Inc. Secures $10.9 Million
January 29th, 2004
BioTrove, Inc. Secures $10.9 Million
BioTrove, Inc. today announced that the company has successfully raised $10.9 million in venture capital funding. The investors supporting the financing include Catalyst Health and Technology Partners, CB Health Ventures, Zero Stage Capital and BioFrontier Partners. The funds will be used to continue the development and commercialization of the Company's micro- and nano-scale products and services, the Living Chip(TM) and Momentum(TM) Assay Development and Screening.
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Aspen Aerogels, Inc. to Present at Canaccord Genuity 34th Annual Growth Conference August 11th, 2014